Thomas William Burns - Mar 22, 2023 Form 4 Insider Report for GLAUKOS Corp (GKOS)

Signature
Diana Scherer, Attorney-in-Fact
Stock symbol
GKOS
Transactions as of
Mar 22, 2023
Transactions value $
$0
Form type
4
Date filed
3/24/2023, 09:09 PM
Previous filing
Mar 16, 2023
Next filing
Apr 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GKOS Common Stock Award $0 +7.29K +1.08% $0.00 680K Mar 22, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GKOS Stock Option (Right to Buy) Award $0 +110K $0.00 110K Mar 22, 2023 Common Stock 110K $48.46 Direct F3
transaction GKOS Stock Option (Right to Buy) Award $0 +7.26K $0.00 7.26K Mar 22, 2023 Common Stock 7.26K $60.78 Direct F4
transaction GKOS Stock Option (Right to Buy) Award $0 +14.7K $0.00 14.7K Mar 22, 2023 Common Stock 14.7K $55.18 Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock underlying a portion of an award of restricted stock units previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation, Nominating and Governance Committee of the Issuer's Board of Directors determined on March 22, 2023 that certain of the operational targets had been achieved. The number of shares of common stock reported herein consists of the portion of the award that was earned based upon the achievement of the operational targets. 50% of the number of shares of common stock reported herein will vest and be delivered in April 2023, and the remaining 50% will vest and be delivered in January 2024.
F2 Includes 67,282 restricted stock units that have not yet vested or been delivered to the Reporting Person.
F3 These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years.
F4 Represents an option to purchase shares of common stock previously granted by the Issuer on April 1, 2022 pursuant to the Reporting Person's election to receive a portion of his annual bonus for 2022 in the form of stock options rather than cash (the "Bonus Election"). The Issuer's Board of Directors determined on March 22, 2023 the annual bonus payable to the Reporting Person pursuant to the Issuer's 2022 executive bonus plan and the number of shares of common stock subject to the stock option earned by the Reporting Person in accordance with the Bonus Election, subject to continued employment through the vesting date. The option to purchase common stock will vest on April 3, 2023.
F5 Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation, Nominating & Governance Committee determined on March 22, 2023 that certain of the operational targets had been achieved. The number of shares of common stock subject to the stock option as reported herein consists of the portion of the award that was earned based upon the achievement of the operational targets.
F6 50% of the portion of the option reported herein will vest and become exercisable in April 2023, and the remaining 50% will vest and become exercisable in January 2024.